Danaher Corp
NYSE:DHR
Danaher Corp
NYSE:DHR
Price:
247.4 USD
-0.34%
Market Closed
Updated:
May 7, 2024
Danaher Corp
Revenue
|
Danaher Corp
Revenue Peer Comparison
Comparables:
TMO
WST
MTD
A
IQV
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Danaher Corp
Revenue Breakdown
Breakdown by Geography
Danaher Corp
Danaher Corp
|
Total Revenue:
23.9B
USD
|
|
North America:
10B
USD
|
|
High-Growth Markets:
7.2B
USD
|
|
Western Europe:
5.5B
USD
|
|
Other Developed Markets:
1.3B
USD
|
Breakdown by Segments
Danaher Corp
Danaher Corp
|
Total Revenue:
23.9B
USD
|
|
Recurring:
18.7B
USD
|
|
Nonrecurring:
5.2B
USD
|
See Also
What is Danaher Corp's Revenue?
Revenue
43.7B
USD
43.7B
USD
Based on the financial report for Mar 29, 2024, Danaher Corp's Revenue amounts to 43.7B USD.
What is Danaher Corp's Revenue growth rate?
Revenue CAGR 10Y
9%
9%
Over the last year, the Revenue growth was 41%. The average annual Revenue growth rates for Danaher Corp have been 21% over the past three years , 21% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
